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Abstract
Background: Nucleotide excision repair (NER) and base excision repair (BER) are the primary mechanisms for repair of bulky
adducts caused by chemical agents, such as PAHs. It is expected that polymorphisms in NER or BER genes may modulate
individual susceptibility to PAHs exposure. Here, we evaluate the effects of PAHs exposure and polymorphisms in NER and
BER pathway, alone or combined, on polycyclic aromatic hydrocarbon-DNA (PAH–DNA) adducts in human sperm.
Methodology/Principal Findings: Sperm PAH-DNA adducts were measured by immunofluorescent assay using flow
cytometry in a sample of 465 infertile adults. Polymorphisms of XPA, XPD, ERCC1, XPF, and XRCC1 were determined by
polymerase chain reaction (PCR) and restriction fragment length polymorphism (RFLP) techniques. The PAHs exposure was
detected as urinary 1-hydroxypyrene (1-OHP) levels. In multivariate models adjusted for potential confounders, we observed
that XRCC1 59pUTR -T/C, Arg194Trp, Arg399Gln polymorphisms were associated with increased sperm adduct levels.
Furthermore, the stratified analysis indicated that adverse effects of XRCC1 Arg194Trp, Arg399Gln polymorphisms on PAH-
DNA adducts were detected only in the high PAHs exposure group.
Conclusions/Significance: These findings provided the first evidence that polymorphisms of XRCC1 may modify sperm PAH-
DNA adduct levels and may be useful biomarkers to identify individuals susceptible to DNA damage resulting from PAHs
exposure.
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Introduction
Over the last two decades, there has been a growing concern
regarding the progressive decline in male fertility [1,2]. Although
possible reasons remain unclear, several studies have reported
associations between exposure to some environmental chemicals
and poor sperm function [3–7]. Recently, polycyclic aromatic
hydrocarbons (PAHs) are received more and more attentions
because they are widespread and prone to attack DNA by forming
PAH-DNA adducts [8,9].
In China, due to the conventional eating habits that involve
heavily fried, roasted, or grilled foods and the rapid increase of
automobile and industrial production, the general population has
more opportunities to be exposed to PAHs from multiple sources
and routes compared to other nations. However, it is difficult to
assess the exact exposure levels of PAHs from multiple routes.
Recently, the urinary metabolite 1-hydroxypyrene (1-OHP) has
been extensively characterized and may reflect internal PAHs
exposure as a sensitive biomarker [10,11]. Our previous studies
among Chinese men have assessed the non-occupational exposure
to PAHs by measuring 1-OHP concentrations in urine. Notably, it
is found that the median concentration of CR-adjusted 1-OHP in
our study is almost 16-fold higher than those in U.S. populations
[6]. This result suggests that Chinese adult males are highly
exposed to PAHs in the environment, and possess extremely high
exposure levels, so the potential health hazard of PAHs deserves
more attention in China.
PAHs derive their genotoxic and carcinogenic properties
through their abilities to form PAH-DNA adducts that may be a
potential source of transmissible prezygotic DNA damage in
spermatozoa [12]. Although only limited studies have concerned
DNA adducts in human sperm to date, it has been demonstrated
that PAH-DNA adducts in sperm are correlated with abnormal
sperm morphology, decreased sperm count, declined progressive
motility and impaired fertilization during ICSI (intracytoplasmic
sperm injection) [13–16]. These results suggest that DNA adducts
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13145in sperm can be applied as potential biomarkers in studies of
human infertility.
To cope with the sperm DNA damage caused by genotoxic
adverse factors, the human has developed defensive mechanisms
including several DNA repair pathways that faithfully remove
DNA lesions. Although the main pathway for removal of bulky
DNA adducts is the nucleotide excision repair (NER), it has been
shown that the base excision repair (BER) mechanism may also
participate in adduct repair [17]. Recently, common genetic
polymorphisms in DNA repair genes are hypothesized to result in
reduced capabilities of DNA damage repair, and thus may be a
useful biomarker to identify individuals sensitive to the environ-
mental genotoxic chemical.
In the present study, we detected PAH-DNA adducts in
ejaculated sperm of infertile adults environmentally exposed to
low levels of PAHs, and evaluated their relation with functional
SNPs in XPA, ERCC1, XPD, XPF, and XRCC1. Furthermore, we
also addressed the interaction between these genetic polymor-
phisms and PAHs exposure on sperm PAH-DNA adducts levels.
To the best of our knowledge, this is the first study that investigates
the effects of low levels PAHs exposure and DNA repair
polymorphism, alone or combined, on sperm PAH-DNA adducts.
Results
To assess the efficiency and concordance of flow cytometry and
fluorescence microscopy, we applied these two approaches in a
total of 46 human sperm samples. A good correlation is detected
between the results as measured by flow cytometry and
fluorescence microscopy (Figure 1; r=0.88, P,0.001). In
Figure 2, representative immunofluorescent images of a negative
control and a sample are shown. As can be seen clearly, the sample
showed clear fluorescence signals of binding to PAH-DNA adducts
(Figure 2A), whereas only minimal staining was observed in
negative control (Figure 2B). With flow cytometry, the negative
control showed low fluorescence (Figure 3A, MIF: 2.71) while the
sample showed strong fluorescence (Figure 3B, MIF: 88.34).
These results suggested that immunofluorescence method using
BPDE-DNA (5D11) monoclonal antibody is useful for both in situ
and flow cytometry detection of sperm PAH-DNA adducts.
Compared to fluorescence microscopy, flow cytometry allows the
Figure 1. Comparison of immunofluorescence analysis by flow
cytometry and fluorescence microscopy in 46 patients.
doi:10.1371/journal.pone.0013145.g001
Figure 2. Sperm PAH-DNA adducts was detected by an immunofluorescence staining with FITC-labeled antibody (green), sperm
DNA was counterstained with DAPI (blue). (A) A sample (B) Negative control untreated with 5D11 monoclonal antibody.
doi:10.1371/journal.pone.0013145.g002
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as automatic analysis of thousands of cells in a few seconds and
therefore was used in this study.
The distribution profiles of sperm PAH-DNA adducts and urine
1-OHP levels among 465 patients, as shown in Figure S1, S2,
underwent natural logarithmic transformation for further associa-
tion studies. The individual characteristics and the effects on sperm
PAH-DNA adducts and urinary 1-OHP levels were exhibited in
Table 1. Significantly increased levels of PAH-DNA adducts were
observed in subjects with high levels of urinary 1-OHP, which was
supported by the Pearson correlation analysis (r=0.262, P=0.003)
(Figure 4). Moreover, we found that the dietaryintake of PAH-rich
meals significantly influenced sperm adduct levels. Subjects who
consume PAH-rich meals $3 times/week had significantly higher
adduct levels than those who did not (mean 6 S.D., 3.6260.94
versus 3.3560.86; P=0.043). Other characteristics, such as age,
cigarette smoking, alcohol drinking, and area of residence appeared
to have no obvious effects on sperm PAH-DNA adduct levels.
Figure 3. Detection of immunofluorescence staining by flow cytometry. Relative cell numbers (ordinate) and fluorescence intensity on a
log10 scale (abscissa) are indicated. A negative control with fluorescence intensity (MIF) of 2.71% (A) and a sample with MFI of 88.34% (B) were
illustrated.
doi:10.1371/journal.pone.0013145.g003










(Mean ± S.D.) p
c
Age (years)
,31 230 (49.5) 3.3660.83 0.370 0.7460.61 0.720
$31 235 (50.5) 3.4360.85 0.7660.60
Smoking status
Never 173 (37.2) 3.3560.80 0.7060.58
Current 249 (53.5) 3.4160.81 0.452 0.7760.60 0.600
Former 43 (9.2) 3.4960.95 0.324 0.8960.66 0.187
Drinking status
Yes 73 (15.7) 3.3360.92 0.570 0.7460.50 0.794
No 392 (84.2) 3.3960.81 0.7660.62
Area of residence
Rural 198 (42.6) 3.4560.88 0.239 0.7460.58 0.655
Urban/suburban 267 (57.4) 3.3660.76 0.7760.62
Consumption of charcoaled food
0 298 (64.1) 3.3560.86 0.7260.59
1–2/week 117 (25.2) 3.4260.89 0.460 0.7860.61 0.657
$3/week 50 (10.8) 3.6260.94 0.043 0.9260.64 0.086
Urinary 1-OHP (mg/g of CR)
a, b
#0.71 232 (50.0) 3.3060.82 0.010 0.2760.35 ,0.001
.0.71 233 (50.0) 3.4960.81 1.2460.37
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and adduct levels were evaluated by multiple linear regression
among 465 patients (Table 2). Given the sample size of our study,
for all SNPs we assumed a dominant mode of inheritance.
Compared with the XRCC1 59UTR TT homozygotes, the XRCC1
59UTR TC heterozygotes carriers showed significantly higher
adduct levels (mean 6 S.D., 3.3560.82 versus 3.6060.80,
P=0.012). Furthermore, we observed that individuals carried
the XRCC1-194 T allele or XRCC1-399 AA homozygotes
displayed markedly higher levels of PAH-DNA adducts, compared
with the wild-type homozygote. However, no obvious associations
were observed between the other DNA repair genetic polymor-
phisms and adduct levels in total sample.
For a better understanding of potential effects of environmental
and genetic factors on the formation of sperm adducts, we
examined whether there existed interactions between DNA repair
genetic polymorphisms and PAHs exposure. Exposure variables
were dichotomized into a low- and a high-exposure group by the
urinary 1-OHP levels median value (natural log transformed:
0.71 mg/g of CR). Significantly higher levels of adducts were
detected in carriers of the XRCC1-194 T allele compared with the
wild-type homozygotes only in high-exposure group (Table3;
Figure 5). Similar result was observed for the XRCC1 Arg399Gln
polymorphisms. These results indicated a joint effect between
DNA repair genetic polymorphisms and PAHs exposure on
susceptibility to sperm PAH-DNA adducts.
Discussion
Increasing attentions have recently focused on genetic poly-
morphisms that could modulate human responses to genotoxic
insults [18,19]. However, whether genetic polymorphisms influ-
ence the susceptibility of human sperm DNA to toxicant-induced
damage is largely unknown. The present study focused specifically
on the effects of common DNA repair genetic polymorphisms on
PAH-DNA adducts in sperm.
We observed a significant association between XRCC1 59UTR -
T/C, XRCC1 Arg194Trp, and XRCC1 Arg399Gln polymorphisms
and the PAH-DNA adduct formation in sperm. It is notable
because XRCC1 polymorphisms may modify sperm PAH-DNA
adducts levels, and hence, may be a useful biomarker to identify
individuals susceptible to sperm DNA damage resulting from
PAHs exposure. Moreover, the adverse effects of XRCC1
Arg194Trp and XRCC1 Arg399Gln were detected only among
high PAHs exposure subjects. Similar to our previous studies, we
observed a joint effect between XRCC1 Arg399Gln and PAHs
exposure on the susceptibility to sperm DNA fragmentation and
male infertility [20]. These findings provided a gene-environment
interaction between PAHs exposure and XRCC1 genetic polymor-
phisms, and might be of concern owing to the ubiquitous exposure
among the non-occupational population.
XRCC1 encodes an important BER pathway protein that is
essential in drawing different components of BER to the sites of
DNA damage and promoting repair efficiency [21]. In rodents
and primates, the expression of XRCC1 gene is significantly higher
in testis than other tissues, implicating a role in the maintenance of
genetic integrity during spermatogenesis [22,23]. Four functional
polymorphisms T-77C, Arg194Trp, Arg280His and Arg399Gln,
have been shown to alter DNA repair capacity (DRC) in some
Figure 4. The correlation between the natural log transformed
of the urinary 1-OHP and the natural log transformed of sperm
PAH-DNA addcuts (r=0.262, P=0.003).
doi:10.1371/journal.pone.0013145.g004
Table 2. Effects of DNA repair genetic polymorphisms on
sperm PAH-DNA adducts.
Genotype Subjects PAH-DNA adductsa P
b, c
N (%) Mean ± S.D. Range
XRCC1 59UTR
TT 379 (81.5) 3.3560.82 1.13–5.45 Reference
TC 84 (18.1) 3.6060.80 1.65–5.48 0.012
CC 2 (0.4) 3.4660.77 2.92–4.01 0.844
XRCC1 Arg194Trp
CC 229 (49.2) 3.2960.82 1.13– 5.48 Reference
CT 197 (42.4) 3.4660.80 1.41–5.33 0.034
TT 39 (8.4) 3.7160.82 1.75–5.45 0.003
XRCC1 Arg280His
GG 375 (80.7) 3.4060.83 1.13–5.48 Reference
GA 83 (17.8) 3.3760.77 1.77–4.87 0.738
AA 7 (1.5) 3.2960.87 2.38–4.44 0.725
XRCC1 Arg399Gln
GG 239 (51.4) 3.3760.78 1.52–5.48 Reference
GA 184 (39.6) 3.3660.83 1.13–5.36 0.922
AA 42 (9.0) 3.6960.94 1.54–5.45 0.018
XPA 59UTR
GG 115 (24.7) 3.3560.84 1.41–5.45 Reference
GA 246 (52.9) 3.4060.85 1.13–5.48 0.611
AA 104 (22.4) 3.4560.87 1.52–5.08 0.390
XPD Lys751Gln
GG 400 (86.0) 3.4060.81 1.41–5.48 Reference
GA + AA 65 (14.0) 3.3660.88 1.13–5.36 0.837
ERCC1 39UTR
GG 209 (44.9) 3.3560.80 1.61–5.45 Reference
GA 212 (45.6) 3.4360.82 1.13–5.48 0.325
AA 44 (9.5) 3.4760.95 1.41–5.28 0.390
XPF Ser835Ser
CC 248 (53.3) 3.3660.82 1.13–5.45 Reference
CT 182 (39.1) 3.4560.79 1.61–5.36 0.304




cAdjusted for consumption of charcoaled food and urinary 1-OHP levels.
doi:10.1371/journal.pone.0013145.t002
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with PAH-DNA adduct levels. Consistent with our study, several
previous studies report that the variant alleles of XRCC1
Arg194Trp and XRCC1 Arg399Gln are associated with a higher
level of DNA adducts in lymphocytes or lung tissue [24–26].
However, the difference between sperm and lymphocytes should
be noted. Different from the somatic cell, mature sperm cells
(spermatids and spermatozoa) have minimal DNA repair capacity,
once their chromatin has condensed. Thus the formation of
adducts during the late stage of spermatogenesis would not be
repaired, leaving the possibility of accumulation of adducts during
spermatogenesis. Contrary to expectation, Horak et al [14]
observe significantly lower levels of bulky DNA adducts in sperm
than those in lymphocytes. It has been proposed that the blood-
testis barrier, compact nature of sperm chromatin and effective
repair of DNA damage during early stages of spermatogenesis may
be the possible mechanisms.
Tobacco smoking and dietary habits with the frequent
consumption of charcoal-grilled food are the most important
non-occupational exposures to PAHs [27]. In the present study,
we found that the consumption of PAH-rich meals at least three
times a week contributed significantly to an increase in PAH-DNA
adduct formation, consistent with previous reports [28,29].
However, we did not find any correlation between cigarette
smoking and PAH-DNA adducts in spermatozoa. In agreement
with the present results, a recent study using immunofluorescent
assay also found no relationship between smoking and sperm
PAH-DNA adducts (16). One reason could be the misclassification
of exposure status, since we did not have an objective measure of
smoking, such as cotinine levels. By the determination of cotinine
levels in seminal plasma or urine (as an internal dosimeter of
cigarette smoke), significant positive associations between PAH-
DNA adducts and cotinine levels are found [12,26,30]. It is also
possible that the benzo(a)pyrene from tobacco smoke does not
reach the target tissue sufficiently to produce detectable adduct
levels in sperm cells. Thus, it is suggested that sperm cells may not
be as sensitive to the effects of smoking as other tissues [31,32].
The strengths of present study include its high participation rate
(.95%), and both genotyping and internal biological markers of
exposure available. In particular, we use a sensitive biomarker, the
urinary 1-OHP, to assess individual PAHs exposure levels. In
addition, urinary metabolites tests can account for the majority of
exposure sources and routes. There are also several potential
limitations to our study. First, men who visit hospitals may differ
from those in general population, and therefore be more
‘‘susceptible’’ to PAHs with a possibility of reporting bias. Second,
we only considered those functional SNPs based on prior
knowledge, rather than a comprehensive tagging SNP-based
approach that would capture most of genetic variations in each
gene. Therefore, we cannot discard a potential role of those DNA
repair genes in which we did not find associations.
In conclusion, this is the first epidemiologic study to explore the
effects of PAHs exposure at general population levels and DNA
repair polymorphisms, alone or combined, on sperm PAH-DNA
adducts. These observations support the notion of combined
influences of genetic susceptibility and environmental exposure on
male reproductive parameters. A more comprehensive genetic
approach in a larger study population is valuable for further studies.
Materials and Methods
Study subjects and sample collection
Study subjects were diagnosed with unexplained male factor
infertility from affiliated hospitals of Nanjing Medical University
between March 2004 and October 2007 (NJMU Infertile Study).
The protocol and consent form were approved by the Institutional
Review Board of Nanjing Medical University prior to the study.
All activities involving human subjects were done under full
compliance with government policies and the Helsinki Declara-
tion. Consecutive eligible men (with wives not diagnosed as
infertile) were recruited to participate. There were no significant
differences in sampling numbers among years and seasons. After
the study procedures were explained and all questions were
answered, subjects signed informed consent forms. All participants
completed an informed consent and a questionnaire including
detailed information, such as age, cigarette smoking, alcohol
drinking, dietary habits, residence and other activities that might
be expected to influence PAHs exposure. Each subject donated 5
ml of blood for genomic DNA extraction and a single spot urine
Table 3. Associations between DNA repair polymorphisms
and sperm PAH-DNA adducts stratified by urinary 1-OHP
levels.
Genotypes Low-exposure group High-exposure group








TT 190 (3.3560.82) Ref 189 (3.3560.77) Ref
TC + CC 42 (3.3760.78) 0.742 44 (3.6560.98) 0.166
XRCC1 Arg194Trp
CC 125 (3.3660.80) Ref 104 (3.2060.83) Ref
CT 91 (3.3860.84) 0.873 106 (3.5260.77) 0.004
TT 16 (3.6460.78) 0.190 23 (3.7660.85) 0.003
XRCC1 Arg280His
GG 186 (3.3960.83) Ref 189 (3.4160.83) Ref
GA 44 (3.3960.76) 0.971 39 (3.3560.79) 0.661
AA 2 (2.8060.59) 0.310 5 (3.4960.94) 0.840
XRCC1 Arg399Gln
GG 116 (3.4460.79) Ref 123 (3.3060.76) Ref
GA 98 (3.3260.84) 0.265 86 (3.4160.83) 0.328
AA 18 (3.4160.86) 0.875 24 (3.9160.96) 0.001
XPA 59UTR
GG 64 (3.2860.76) Ref 51 (3.4360.83) Ref
GA 119 (3.3760.88) 0.527 127 (3.4260.80) 0.952
AA 49 (3.5560.92) 0.115 55 (3.3660.86) 0.626
XPD Lys751Gln
GG 197 (3.3060.82) Ref 203 (3.5060.79) Ref
GA + AA 35 (3.2960.85) 0.961 30 (3.4560.92) 0.732
ERCC1 39UTR
GG 102 (3.3360.87) Ref 107 (3.3760.82) Ref
GA 110 (3.4360.75) 0.396 102 (3.4360.72) 0.636
AA 20 (3.3760.89) 0.875 24 (3.5760.91) 0.332
XPF Ser835Ser
CC 126 (3.3160.86) Ref 122 (3.4260.78) Ref
CT 87 (3.3160.76) 0.982 95 (3.5760.80) 0.163




cAdjusted for consumption of charcoaled food.
doi:10.1371/journal.pone.0013145.t003
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semen sample. Urine samples were frozen at 220uC until analyses
for PAHs metabolites. Totally, 465 subjects whose genotyping
data, PAH metabolites and PAH-DNA adducts measures were
available were included in this study.
PAH-DNA adducts determination: Immunofluorescence
staining
PAH-DNA adducts were measured by an indirect immunoflu-
orescence method using BPDE-DNA (5D11) monoclonal antibody
(sc-52625; Santa Cruz Biotechnology, Santa Cruz CA), with
FITC-conjugated secondary antibody. Although, 5D11 recognizes
BPDE-DNA adducts, it also cross-reacts with other structurally
related PAHs in various affinities; hence the terminology PAH-
DNA is commonly used [33–36]. The intensity of FITC
fluorescence was then detected by the FACSCalibur flow
cytometer (BD Biosciences Pharmingen).
In brief, washed sperm were resuspended in 2% paraformal-
dehyde for 30 min at room temperature. After washing with PBS,
samples were resuspended in permeabilization solution (0.2%
Triton X-100, 0.1% sodium citrate) for 10 min on ice. Samples
were washed twice with 16PBS, treated with 100 mg/ml RNase at
37uC for 1 h, then with proteinase K (10 mg/ml in at room
temperature) for 10 min. To denature the DNA, samples were
incubated with 4N HCl for 10 min followed by 50 mM Tris-base
(5 min at room temperature). After blocking with 5% normal goat
serum in Tris buffer (45 min at 37uC), samples were then
incubated with mouse monoclonal antibody raised against
BPDE-I-G (dilution 1:50 in PBS; overnight at 4uC). After washing
with PBS, samples were incubated with fluorescein isothiocyanate
(FITC)-conjugated goat anti-mouse IgG (dilution 1:200 in PBS) at
37uC for 45 min. Samples were washed with PBS, and then
analyzed immediately by flow cytometry. We analysed 10,000
individual sperm per sample for FITC fluorescence emissions.
Mean fluorescence intensity (MFI) was calculated on a logarithmic
scale. For each batch, a negative control with normal mouse IgG
instead of the 5D11 was performed.
To assess the reliability and concordance of flow cytometry and
fluorescence microscopy, 46 semen samples were analyzed
simultaneously with both techniques. The immunofluorescence
microscopy used for the analysis of DNA adducts was carried out
as described previously [16]. Slides were examined with a confocal
laser-scanning microscope LSM 710 (Carl Zeiss, Germany). The
quantitative analysis of the average fluorescent intensity was
measured directly in five fields for each slide by LSM 710 ZEN
software (Carl Zeiss) and the mean value was calculated.
Urinary PAHs metabolites measurement
The urine 1-OHP, as a sensitive PAHs-exposure biomarker, was
determined by LC-MS/MS as previously described [6]. The
analytes underwent hydrolysis using b-glucuronidase/arylsulfatase
(98%, Sigma-Aldrich, England) and separated from the matrix by
solid-phase extraction. Then, the metabolites were detected by
LC-MS/MS. The limit of detection for 1-OHP was 0.15 mg/l.
Creatinine (CR) concentrations were used to adjust PAHs
concentrations for variable urine dilution in spot samples. Samples
with CR concentrations .300 or ,30 mg/dl were considered too
concentrated or too dilute to provide valid results and were
excluded from the primary analysis.
Genotyping
DNA was extracted from peripheral blood lymphocytes by
standard methods, resuspended in Tris-EDTA buffer (10 mM
Tris, 1 mM EDTA), and frozen until use. We genotyped the
following SNPs: XRCC1 59UTR -T/C (rs3213245), XRCC1
Arg194Trp (rs1799782), XRCC1 Arg280His (rs25489), XRCC1
Arg399Gln (rs25487), XPA 59UTR -C/T (rs1800975), XPD
Asp312Asn (rs1799793), ERCC1 39UTR G/T (rs3212986), and
XPF Ser835Ser (rs1799801). Genotype analysis of all SNPs was
done using polymerase chain reaction (PCR) and restriction
fragment length polymorphisms (RFLP) techniques. Genotypes of
XRCC1, XPA 59UTR, ERCC1 39UTR and XPD Lys751Gln were
determined as described previously [37,38]. XPF Ser835Ser
polymorphism was detected using the following primers: 59-
CTGAAACAAAGCAAGCCACA-39 (forward) and 59- GA-
CAGGGCTGCTAATTCTGC-39 (reverse). The 194 bp PCR
product was digested overnight by Cail enzyme (MBI Fermentas)
and obtained the A/A (194 bp), A/G (194, 130, 64 bp) and G/G
Figure 5. Sperm PAH-DNA adducts and effects of XRCC1 Arg194Trp, Arg399Gln polymorphisms stratified by urinary 1-OHP levels.
doi:10.1371/journal.pone.0013145.g005
XRCC1 and PAH-DNA Adducts
PLoS ONE | www.plosone.org 6 October 2010 | Volume 5 | Issue 10 | e13145(130, 64 bp) genotypes. For quality control, 10% of the samples
were randomly genotyped again, and the reproducibility was
100%.
Statistical analysis
The statistical analyses were performed with the using the Stata
statistical package (Version 7.0; StataCorp, LP, USA). All tests
were two-sided and the significance level was set at P,0.05.
Sperm PAH-DNA adducts was presented as mean 6 standard
deviations (SD). For sperm PAH-DNA adducts and urinary 1-
OHP levels were non-normally distributed (checked by skewness-
kurtosis tests), these two variables were transformed to achieve
normal distributions using the lnskew0 function (natural log
transformed). The effects of selected individual characteristics on
sperm PAH-DNA adducts were analyzed by t test. A Scatter plot
and Pearson correlation analysis were conducted to evaluate the
relationship between urinary 1-OHP levels and PAH-DNA
adducts. Multiple linear regression analysis was applied for the
comparison of PAH-DNA adducts as considered for the genotypes
of each SNP. Age, smoking status, drinking status, area of
residence and habitual consumption of charcoaled food were
considered as potential confounders. These selected individual
characteristics were included in the final models if they showed
any association (P,0.20) with sperm PAH-DNA adducts.
Supporting Information
Figure S1 Distributions of sperm PAH-DNA adducts in 465
ejaculates. (A), adduct values without logarithmic transformation.
(B), adduct values underwent natural logarithmic transformation.
Found at: doi:10.1371/journal.pone.0013145.s001 (0.40 MB TIF)
Figure S2 Distribution of urine CR-adjusted 1-hydroxypyrene
1-OHP levels in 465 patients. (A), 1-OHP values without natural
logarithmic transformation. (B), 1-OHP values underwent natural
logarithmic transformation.
Found at: doi:10.1371/journal.pone.0013145.s002 (0.41 MB TIF)
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